Allogeneic hematopoietic stem cell transplantation could improve survival of cytogenetically normal adult acute myeloid leukemia patients with DNMT3A mutations.

Xu, Yang

Allogeneic hematopoietic stem cell transplantation could improve survival of cytogenetically normal adult acute myeloid leukemia patients with DNMT3A mutations. [electronic resource] - American journal of hematology Nov 2015 - 992-7 p. digital

Publication Type: Journal Article

1096-8652

10.1002/ajh.24135 doi


Adolescent
Adult
Aged
Antineoplastic Agents--therapeutic use
CCAAT-Enhancer-Binding Proteins--genetics
Cytogenetic Analysis
DNA (Cytosine-5-)-Methyltransferases--genetics
DNA Methyltransferase 3A
Female
Gene Expression
Hematopoietic Stem Cell Transplantation
Humans
Leukemia, Myeloid, Acute--genetics
Male
Middle Aged
Multivariate Analysis
Mutation
Nuclear Proteins--genetics
Nucleophosmin
Prognosis
Remission Induction
Retrospective Studies
Survival Analysis
Transplantation, Homologous
fms-Like Tyrosine Kinase 3--genetics